Latest Content

Recent Breast Cancer News and Updates Patients May Have Missed

March 6th 2021, 4:00pm

By Ryan McDonald

Article

A roundup of some of the latest news and updates for patients with breast cancer from CURE®

FDA Approves Yescarta for Third-Line Treatment of Relapsed or Refractory Follicular Lymphoma

March 6th 2021, 2:06am

By Darlene Dobkowski, MA

Article

This accelerated FDA approval is the first CAR T-cell therapy approved for the treatment of patients with indolent follicular lymphoma.

FDA Rejects Approval of Oral Paclitaxel Plus Encequidar for Metastatic Breast Cancer: Here’s Why

March 5th 2021, 9:00pm

By Brielle Benyon

Article

Last week, the Food and Drug Administration (FDA) was scheduled to make a decision on whether or not they would approve oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The agency decided not to approve the regimen, and issued a complete response letter outlining why.

FDA, Drug Manufacturer Pull Keytruda’s Indication for Small Cell Lung Cancer

March 5th 2021, 7:00pm

By Brielle Benyon

Article

Merck – the manufacturer of Keytruda (pembrolizumab) – is pulling the immunotherapy drug’s indication for patients with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy and one or more prior line of therapy.

Why Do I Write About My Cancer Journey?

March 5th 2021, 5:00pm

By William Ramshaw

Article

A pancreatic cancer survivor shares why he writes about his journey and encourages other patients and survivors to do the same.

Friday Frontline: Biden Holds Bipartisan Meeting on Cancer Research, Pediatric Patient ‘Donates’ Her Birthday to Help Other Children and More

March 5th 2021, 4:00pm

By Jessica Skarzynski

Article

From President Biden convening a bipartisan meeting to discuss cancer treatments and research to a 5-year-old patient with hepatoblastoma asking for donations to a local food bank instead of presents for her birthday, here’s what’s happening in the cancer space this week.

Organization Urges That Patients With Lung Cancer Worldwide Have Access to COVID-19 Vaccine

March 5th 2021, 2:00pm

By Ryan McDonald

Article

The International Association for the Study of Lung Cancer recently joined more than 100 cancer centers and organizations in urging leading public health officials to prioritize administering the COVID-19 vaccine to cancer survivors and patients undergoing treatment for the disease.

Why It’s Important to ‘Live Well With Your Cancer’

March 4th 2021, 10:00pm

By Jessica Skarzynski

Video

While it is important to educate oneself after receiving a diagnosis of cancer, it’s also critical to know when to step away and find a balance between cancer and life, according to Diane Zipursky-Quale.

Novel Program May Make Exercise More Accessible to Patients with Cancer

March 4th 2021, 7:00pm

By Antonia DePace

Article

Having an exercise professional in chemotherapy infusion suites could significantly benefit patients with cancer and help improve health-related outcomes such as fatigue, according to recent study results.

While Cancer is Not Fun, There is Hope Every Day

March 4th 2021, 5:00pm

By Julie S. Brokaw

Article

An ovarian cancer survivor shares that although she’s been frustrated and mad about a recent recurrence in her lymph nodes, she still celebrates the life that she’s been blessed with.

‘No Excuses’ When It Comes to Colorectal Cancer Awareness

March 4th 2021, 4:00pm

By Jessica Skarzynski

Podcast

This week on the “CURE® Talks Cancer” podcast, to kick off Colorectal Cancer Awareness Month, we spoke with colon cancer survivor April Schack about what it was like to be diagnosed at age 36 and how she’s working with Fight CRC on a new campaign that aims to raise awareness about the disease, so that no one has to go through what she did.

Depression Plays a Role in Cancer-Related Fatigue

March 4th 2021, 2:00pm

By Brielle Benyon

Article

Women with a history of depression had higher rates of cancer-related fatigue, according to recent study results.

FDA Approves Lorbrena as First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer

March 4th 2021, 2:08am

By Darlene Dobkowski, MA

Article

This approval expands a previous accelerated approval of the drug in 2018, allowing it for use in patients with brain metastases.

Understanding Triple-Negative Breast Cancer

March 3rd 2021, 10:00pm

By Kristie L. Kahl

Video

CURE spoke with Dr. Ogori Kalu, on behalf of the Triple-Negative Breast Cancer Foundation, about the psychosocial effects from a diagnosis, as well as treatment and its side effects.

Imbruvica Plus Novel Agent May Improve Progression-Free Survival in Chronic Lymphocytic Leukemia

March 3rd 2021, 7:00pm

By Darlene Dobkowski, MA

Article

Patients treated with Imbruvica plus TG-1101 had an overall response rate of 83% compared with 65% in those treated with Imbruvica alone.